REVIEW
Accepted on 13 Oct 2025
Unlocking New Horizons in Oncology: Ivonescimab's Dual-Target Approach to Anti-VEGF/PD-1(L1) Therapy
doi 10.3389/fimmu.2025.1599181
- 226 views
15k
Total downloads
62k
Total views and downloads
REVIEW
Accepted on 13 Oct 2025
ORIGINAL RESEARCH
Published on 31 Jul 2025
CASE REPORT
Published on 22 Jul 2025
ORIGINAL RESEARCH
Published on 16 May 2025
REVIEW
Published on 17 Apr 2025
REVIEW
Published on 11 Apr 2025
REVIEW
Published on 19 Feb 2025
REVIEW
Published on 25 Nov 2024
ORIGINAL RESEARCH
Published on 21 Nov 2024
ORIGINAL RESEARCH
Published on 20 Nov 2024
CASE REPORT
Published on 01 Nov 2024
REVIEW
Published on 30 Oct 2024
